How China's innovative pharmaceutical industry accelerates with regulatory reform

Regulatory reforms have accelerated innovation in China's pharmaceutical industry by shortening approval times, encouraging new drug research, raising international standards, and promoting clinical trials. Consequently, domestic enterprises have enhanced their innovation capabilities and global competitiveness.